The new development will arm healthcare providers with a vital tool to address the steep rise of malaria […]

The news arrives after the tenth recorded positive Omicron case in Scotland, which the government has confirmed has […]

Bayer pads blockbuster case for Nubeqa with phase 3 win in metastatic prostate cancer fkansteiner Fri, 12/03/2021 – […]

Biogen’s Spinraza, Fosun-Kite’s Yescarta and a controversial Alzheimer’s drug: All you need to know about China’s new state […]

AstraZeneca blocks investor group’s $7.6B buyout of rare disease specialist Sobi: report fkansteiner Fri, 12/03/2021 – 09:18

Fierce Pharma Asia—China’s insulin price cut; Astellas-Dyno gene therapy deal; Fujifilm’s U.K. investment aliu Fri, 12/03/2021 – 10:10

Questions posed by conservative justices of the US Supreme Court during oral arguments on 1 December have indicated […]

Thacker’s article on integrity issues in Pfizer’s vaccine trial is interesting from at least two vantage points.1 First, […]

Australia is one of the countries most at risk from climate change, but is a laggard in responding, […]

A team led by researchers at Massachusetts General Hospital (MGH) has demonstrated ​​that magnetic resonance imaging (MRI) and […]